Atlas Trials

Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Clinical trial NCT02115659 · UNKNOWN

Trial details

NCT number
NCT02115659
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Start date
2014-04-01
Primary completion
2016-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.